169 results on '"Buprenorphine -- Dosage and administration"'
Search Results
2. Researchers at Medical College of Wisconsin Target Opioids (Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder)
3. Research on Opioids Detailed by a Researcher at Boston Medical Center (Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation ...)
4. Investigators from University of North Carolina Release New Data on Central Nervous System Agents (A Brief Online Training To Address Pharmacists' Willingness To Dispense Buprenorphine)
5. Research from Virginia Commonwealth University Yields New Findings on Prescription Opioids (Association of Receipt of Opioid Prescription for Acute Post-Delivery Pain Management with Buprenorphine Discontinuation among Postpartum People with ...)
6. Reports Outline Opioids Study Results from Stanford University (Estimated Effectiveness and Cost-effectiveness of Opioid Use Disorder Treatment Under Proposed Us Regulatory Relaxations: a Model-based Analysis)
7. New Opioids Findings from Postgraduate Institute of Medical Education and Research Described [Neurocognitive Functions After 6-month Buprenorphine (Naloxone)-based Opioid Agonist Maintenance Treatment]
8. Baystate Health Researcher Broadens Understanding of Opioids (Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes)
9. Researchers from King's College London Detail Research in Opioids (Patients' goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study)
10. Findings on Opioids Reported by Investigators at Baylor University (Prevalence of Buprenorphine Providers Requiring Cash Payment From Insured Women Seeking Opioid Use Disorder Treatment)
11. Association between opioid overdose and health plan disenrollment with mitigating impact of buprenorphine initiation
12. University of Washington School of Medicine Researchers Publish Findings in Opioids (Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study)
13. Brown University School of Public Health Researchers Yield New Study Findings on Opioids (Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a ...)
14. Researchers from University of Arkansas for Medical Sciences Provide Details of New Studies and Findings in the Area of Opioids (Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active ...)
15. New Opioids Study Findings Have Been Reported from Charite University Hospital and School of Medicine (The Switching Process From Buprenorphine Sublingual Tablets To the Monthly Buprenorphine Subcutaneous Depot Injection In Opioid Dependent ...)
16. US FDA approves Braeburn's Brixadi extended-release subcutaneous injection for moderate to severe opioid use disorder
17. Reports from University of Tennessee Provide New Insights into Opioids (Use of a Sequential Multiple Assignment Randomized Trial To Test Contingency Management and an Integrated Behavioral Economic and Mindfulness Intervention for ...)
18. Study Data from University of Puerto Rico Medical Sciences Campus Update Knowledge of Opioids (348 Translating a precision dosing approach for opioid use disorder in Puerto Rico: Pilot testing of the clinical utility and patient/provider ...)
19. New Opioids Study Findings Recently Were Reported by Researchers at North Carolina Department of Health and Human Services (Transitioning From High-dose Methadone To Buprenorphine Using a Microdosing Approach: Unique Considerations At Asam ...)
20. New Opioids Study Results from University of Alabama Birmingham Described (Physicians' Experiences With Buprenorphine: a Qualitative Study of Motivations for Becoming X Waivered and Barriers To and Facilitators of Prescribing the Medication for ...)
21. Findings from Brown University Warren Alpert Medical School Advance Knowledge in Opioids (Buprenorphine involvement in opioid overdose deaths: A retrospective analysis of postmortem toxicology in Marion County, Indiana, 2015-2021)
22. Medication-Assisted Treatment for Opioid Use Disorder
23. Data on Infectious Diseases and Conditions Discussed by a Researcher at Emory University (Prevalence, Distribution, and Characteristics Associated with Possession of Buprenorphine Waivers Among Infectious Diseases Physicians in the United States)
24. Researchers from University of North Carolina Describe Findings in Central Nervous System Agents (North Carolina Community Pharmacists' Buprenorphine Dispensing Practices and Attitudes)
25. New Findings from Columbia University Update Understanding of Opioids (Buprenorphine & Methadone Dosing Strategies To Reduce Risk of Relapse In the Treatment of Opioid Use Disorder)
26. New Opioids Study Findings Has Been Reported by a Researcher at UK Healthcare (Utility of an integrated health system specialty pharmacy in provision of extended-release buprenorphine for patients with opioid use disorder)
27. New Opioids Research from Summa Health System Discussed (Stage-of-change Assessment Predicts Short-term Treatment Engagement for Opioid Use Disorder Patients Initiated on Buprenorphine)
28. Reports Outline Opioids Study Results from Duke University (Buprenorphine Physician-pharmacist Collaboration In the Management of Patients With Opioid Use Disorder: Results From a Multisite Study of the National Drug Abuse Treatment Clinical ...)
29. Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States
30. Addiction treatments in pharmacies could help combat the opioid crisis
31. New Antidotes Findings Has Been Reported by Investigators at Providence Sacred Heart Medical Center (Rapid Transition To Buprenorphine In a Patient With Methadone-related Qtc Interval Prolongation)
32. Studies from Albert Einstein College of Medicine Yield New Data on Opioids (Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation)
33. Findings on Opioids Reported by Investigators at University of Kentucky (The Effect of Medicaid Expansion On State-level Utilization of Buprenorphine for Opioid Use Disorder In the United States)
34. University of Saskatchewan Researchers Add New Study Findings to Research in Opioids (Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic ...)
35. Maternity Care and Buprenorphine Prescribing in New Family Physicians
36. University of North Carolina Chapel Hill Details Findings in Opioids (The Role of Primary Care In the Initiation of Opioid Use Disorder Treatment In Statewide Public and Private Insurance)
37. Studies from Johns Hopkins University Describe New Findings in Opioids (Therapy Dose Mediates the Relationship Between Buprenorphine/naloxone and Opioid Treatment Outcomes In Youth Receiving Medication for Opioid Use Disorder Treatment)
38. Researchers from University of Pennsylvania Report on Findings in Opioids (Sustained Implementation of a Multicomponent Strategy To Increase Emergency Department-initiated Interventions for Opioid Use Disorder)
39. Buprenorphine Provision by Early Career Family Physicians
40. Higher buprenorphine doses help OUD patients
41. Findings from Albert Einstein College of Medicine Update Knowledge of Opioids (Onsite Buprenorphine Inductions At Harm Reduction Agencies To Increase Treatment Engagement and Reduce Hiv Risk: Design and Rationale)
42. Study Results from Oregon Health & Science University (OHSU) in the Area of Opioids Reported (Low-threshold Buprenorphine Via Community Partnerships and Telemedicine-case Reports of Expanding Access To Addiction Treatment During Covid-19)
43. Teens Rarely Get Anti-Addiction Meds When Treated for Opioid Misuse
44. Braeburn's BRIXADI (buprenorphine) Extended-Release Subcutaneous Injection (CIII) Receives FDA Approval for Moderate to Severe Opioid Use Disorder
45. Researchers from Massachusetts Institute of Technology Report on Findings in Central Nervous System Agents [Pharmacokinetics of Single-dose Intramuscular and Subcutaneous Injections of Buprenorphine In Common Marmosets (Callithrix Jacchus)]
46. For Blacks and Hispanics, Treatment for Opioids Is Shorter, Study Finds
47. French Competition Authority Decision: Decision 13-D-21 of December 18, 2013 relating to practices implemented on the French market for high-dose buprenorphine marketed in the community
48. Extended-release monthly buprenorphine injection
49. Braeburn's BRIXADI[TM] buprenorphine Extended-Release Subcutaneous Injection CIII Receives FDA Approval for Moderate to Severe Opioid Use Disorder
50. Comparative evaluation of anaesthetic efficacy and haemodynamic effects of a combination of isobaric bupivacaine with buprenorphine vs. isobaric levobupivacaine with buprenorphine for spinal anaesthesia - A double blinded randomised clinical trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.